⚠ For research purposes only — This certificate relates to the referenced lot only and is not an approval for human or veterinary use.
← Back to CJC-1295 (with DAC)
Lab certificate (PDF)
Atlas RNDQuality Control · Released Records

Certificate of Analysis

DOC QC-COA-0406-CJCDAC-5-006-26 · REV 1
ProductCJC-1295 (with DAC)
SKUATL-0406-5
LotCJCDAC-5-006-26
FormatLyophilized · 5 mg
ReportedJan 22, 2026
LaboratoryAxisPharm
CAS863288-34-0
Storage−20 °C · desiccated
DispositionRELEASED

Triple-tested · Raw material is tested before vialing, the finished vial is tested for sterility, and every lot is released on an independent laboratory certificate.

Test results

Release test results for CJC-1295 (with DAC) lot CJCDAC-5-006-26
TestMethodSpecificationResultVerdict
IdentityLC-MS Observed mass conforms to theoreticalConforms · LC-MS 1826.5 [M+2H], PASS
PurityHPLC-UV ≥ 95%99.40% PASS
Net contentLC-MS · gravimetric Report5.1 mg PASS

Source document

AxisPharm, LLC · Independent analytical laboratory. Reference 22Jan2026-02 · sample received Jan 8, 2026 · reported Jan 22, 2026.

The results above are transcribed from the laboratory's certificate for this lot. Atlas RND hosts a copy of that document; the original is the authority, so open it to confirm every figure.

Laboratory certificate (PDF)

NOT PART OF THIS LABORATORY'S PANEL FOR THIS LOT: APPEARANCE, ENDOTOXIN, MICROBIAL, ELEMENTAL IMPURITIES, FENTANYL SCREEN. ONLY TESTS THE LABORATORY RAN ARE LISTED.

Conclusion. Lot CJCDAC-5-006-26 of CJC-1295 (with DAC) 5 mg meets the release specification for every test listed above and is approved for distribution for laboratory research use only. Testing performed by AxisPharm, LLC, an independent analytical laboratory, independent of Atlas RND.

Issued by the laboratoryAxisPharm, LLC · Jan 22, 2026
Reviewed for releaseAtlas RND quality control
VERIFY THIS DOCUMENT
www.atlasrnd.co/coa/cjcdac-5-006-26
LAB REFERENCE 22Jan2026-02